✦ LIBER ✦

Regional biologic therapy. Hepatic arterial infusion of recombinant human tumor necrosis factor in patients with liver metastases

✍ Scribed by Giora M. Mavligit; Alexander A. Zukixvski; Chuslip Charnsangavej; C. Humberto Carrasco; Sidney Wallace; Jordan U. Gutterman

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 514 KB
Volume: 69
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19920115)69:2<557::aid-cncr2820690246>3.0.co;2-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Severe, symptomatic, dose-limiting hypop

Severe, symptomatic, dose-limiting hypophosphatemia induced by hepatic arterial infusion of recombinant tumor necrosis factor in patients with liver metastases

✍ Auro Del Giglio; Giora M. Mavligit; Alexander A. Zukiwski; Mohamed K. Ali 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 1 views

Twenty-two patients with liver metastases received 45 courses of recombinant tumor necrosis factor (rTNF] by hepatic arterial infusion in doses ranging from 12.5 to 175 pg/m2/d for 5 days by continuous infusion. The induction of statistically significant, dose-related, severe, albeit transient, hypo

Hepatic arterial infusion of human recom

Hepatic arterial infusion of human recombinant tumor necrosis factor-alpha. An experimental study in dogs

✍ Shin-Ichi Ohkawa; Kenneth C. Wright; Harsh Mahajan; Giora M. Mavligit; Sidney Wa 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 694 KB

Local and systemic toxicities associated with hepatic arterial infusion of human recombinant tumor necrosis factor (rTNF) were studied in healthy adult mongrel dogs. The animals received saline containing human serum albumin with or without rTNF (0.02, 0.2, or 2.0 mg/m2). Arteriograms were made, and